CPG 10101
a potent and selective unmethylated cytidine-phosphate-guanosine (CpG)-containing oligodeoxynucleotide agonist of Toll-like receptor 9 (TLR9) for the treatment of chronic infections such as HCV
Also Known As:
ACTILON; CPG ODN 10101
Networked: 2
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Davis, Heather L:
2 articles
(11/2007 - 01/2007)
|
2. | Efler, Susan M:
2 articles
(11/2007 - 01/2007)
|
3. | Afdhal, Nezam H:
1 article
(11/2007)
|
4. | Al-Adhami, Mohammed:
1 article
(11/2007)
|
5. | Bacon, Bruce R:
1 article
(11/2007)
|
6. | Gordon, Stuart C:
1 article
(11/2007)
|
7. | Jacobson, Ira M:
1 article
(11/2007)
|
8. | Lawitz, Eric:
1 article
(11/2007)
|
9. | Lekstrom-Himes, Julie A:
1 article
(11/2007)
|
10. | McHutchison, John G:
1 article
(11/2007)
|
Related Diseases
Related Drugs and Biologics